BioLife Solutions (BLFS) Financial Statements

417 Followers

BioLife Solutions Financial Overview

BioLife Solutions's market cap is currently $1.06B. The company's EPS TTM is $-0.2505; its P/E ratio is 81.66; BioLife Solutions is scheduled to report earnings on May 7, 2026, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 96.21M	$ 82.25M	$ 75.86M	$ 76.24M	$ 119.16M
Gross Profit	$ 62.12M	$ 53.67M	$ 46.75M	$ 46.91M	$ 28.85M
Operating Income	$ -12.13M	$ -7.13M	$ -23.44M	$ -5.92M	$ -35.16M
EBITDA	$ -9.38M	$ 1.53M	$ -45.24M	$ -124.18M	$ -16.65M
Net Income	$ -12.13M	$ -20.18M	$ -66.43M	$ -139.81M	$ -8.91M
Balance Sheet
Cash & Short-Term Investments	$ 88.93M	$ 104.58M	$ 44.18M	$ 62.70M	$ 69.87M
Total Assets	$ 405.88M	$ 399.49M	$ 412.71M	$ 450.23M	$ 552.60M
Total Debt	$ 17.90M	$ 30.17M	$ 33.83M	$ 43.71M	$ 26.88M
Net Debt	$ -15.14M	$ -65.21M	$ 5.93M	$ 24.27M	$ -42.99M
Total Liabilities	$ 34.00M	$ 50.58M	$ 75.05M	$ 86.04M	$ 76.24M
Stockholders' Equity	$ 371.89M	$ 348.91M	$ 337.66M	$ 364.19M	$ 480.75M
Cash Flow
Free Cash Flow	$ 10.64M	$ 5.20M	$ -18.88M	$ -18.87M	$ -13.22M
Operating Cash Flow	$ 20.11M	$ 8.43M	$ -12.50M	$ -8.49M	$ -4.84M
Investing Cash Flow	$ -71.54M	$ 58.30M	$ 17.84M	$ -58.12M	$ -12.64M
Financing Cash Flow	$ -10.92M	$ -6.78M	$ 10.59M	$ 16.32M	$ -2.78M

Currency in USD

BioLife Solutions Earnings and Revenue History

Income Statement >

BioLife Solutions Debt to Assets

Balance Sheet >

BioLife Solutions Cash Flow

Cash Flow >

BioLife Solutions Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >